Telavancin
| Recommendation | 750 mg IV q24h probably adequate for most patients |
|---|---|
| Comments | Data suggest this dose achieves efficacy targets and minimizes risk of nephrotoxicity. If higher systemic exposure is desired, consider 10 mg/kg q24h based on adjusted BW, not to exceed 1000 mg q24h (Pharmacotherapy 2023;43:226). |